Abstract:Early precise diagnosis of cancers is crucial to realize more effective therapeutic interventions with minimal toxic effects. Cancer phenotypes may also alter greatly among patients and within individuals over therapeutic process. The identification and characterization of specific biomarkers expressed on tumor cells are highly demanded for diagnosis and treatment, but remain ongoing challenge. Herein, we designed three new bioorthogonal surface enhanced Raman scattering (SERS) nanoprobes and successfully applied the cocktail of them for MDA-MB-231 and MCF-7 breast cancer multiplex phenotype detection. The SERS nanoprobes containing Raman reporters with diynl, azide or cyano moieties demonstrated apparent Raman shift peaks in 2205 cm-1, 2120 cm-1 and 2230 cm-1, respectively, in biologically Raman-silent region. Three target ligands including oligonucleotide aptamer (AS1411), arginine-glycine-aspatic acid (RGD) peptide and homing cell adhesion molecule antibody (anti-CD44) were respectively conjugated to the nanoprobes for active recognition capability. The cocktail of the nanoprobes manifested minimal cytotoxicity and simultaneously multiplex phenotype imaging of MDA-MB-231 and MCF-7 cells. Quantitative measurement of cellular uptake by in-ductively coupled plasma mass spectrometry (ICP-MS) verified that MDA-MB-231 cells harbored much higher expres-sion level of CD44 receptor than MCF-7 cells. For in vivo SERS detection, Raman shift peaks of 2120 cm-1, 2205 cm-1 and 2230 cm-1 in micro tumor were clearly observed, representing the existence of three specific biomarkers of nucleolin, integrin αvβ3 and CD44 reporter, which could be used for early cancer phenotype identification. The biodistribution results indicated that target ligand modified nanoprobes exhibited much more accumulation in tumors than those nanoprobes without target ligands. The multicolor cocktail of bioorthogonal SERS nanoprobes offers an attractive and insightful strategy for early cancer multiplex phenotype targeting and diagnosis in vivo with non-invasion, low cross-talk, unique spectral-molecular signature, high sensitivity and negligible background interference.

A Two‐Stage Dissociation System for Multilayer Imaging of Cancer Biomarker‐Synergic Networks in Single Cells

Simultaneous Ultrasensitive Detection of Two Breast Cancer Microrna Biomarkers by Using a Dual Nanoparticle/nanosheet Fluorescence Resonance Energy Transfer Sensor

A multi-channel responsive AuNP@COF core-shell nanoprobe for simultaneous subcellular profiling of multiple cancer biomarkers

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

Single-band Upconversion Nanoprobes for Multiplexed Simultaneous in Situ Molecular Mapping of Cancer Biomarkers

Accurate Fluorescence Diagnosis of Cancer Based on Sequential Detection of Hydrogen Sulfide and pH

Quantitative Detection and Imaging of Multiple Biological Molecules in Living Cells for Cell Screening.

2D MOF Nanosensor-Integrated Digital Droplet Microfluidic Flow Cytometry for in Situ Detection of Multiple Mirnas in Single CTC Cells

“Three-in-one” Nanohybrids As Synergistic Nanoquenchers to Enhance No-Wash Fluorescence Biosensors for Ratiometric Detection of Cancer Biomarkers

Multicolor Cocktail for Breast Cancer Multiplex Phenotype Targeting and Diagnosis Using Bioorthogonal Surface-Enhanced Raman Scattering Nanoprobes.

Highly Sensitive Colorimetric Cancer Cell Detection Based on Dual Signal Amplification

A dual-channel fluorescent nanoprobe for accurate cancer diagnosis by sequential detection of adenosine triphosphate and sulfur dioxide

An advanced 3D DNA nanoplatform for spatiotemporally confined enhanced dual-mode biosensing MicroRNA in cancer cell

Target-Induced Core-Satellite Nanostructure Assembly Strategy for Dual-Signal-On Fluorescence Imaging and Raman Quantification of Intracellular MicroRNA Guided Photothermal Therapy

Double Signal Amplification Strategy for Dual-Analyte Fluorescent Aptasensors for Visualizing Cancer Biomarker Proteins

Single-Nanoparticle Differential Immunoassay for Multiplexed Gastric Cancer Biomarker Monitoring

Multiple functional nanoprobe for contrast-enhanced bimodal cellular imaging and targeted therapy.

Smart enzyme-free amplification dual-mode self-powered platform designed on two-dimensional networked graphdiyne and DNA nanorods for ultra-sensitive detection of breast cancer biomarkers

Actively Targeted and Dual-Stimuli-Responsive Branch-Shaped System for Simultaneous MicroRNAs Imaging in Living Cells

Machine Learning-Assisted Pattern Recognition and Imaging of Multiplexed Cancer Cells via Porphyrin-Embedded Dendrimer Array

Cross-talk-free simultaneous fluoroimmunoassay of two biomarkers based on dual-color quantum dots.